| Tretinoin | Approved Investigational Nutraceutical | BAK1 | 578 |
downregulated | Tretinoin results in decreased expression of BAK1 mRNA | 6p21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | BAK1 | 578 |
upregulated | Tretinoin results in increased expression of BAK1 mRNA | 6p21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | BAMBI | 25805 |
downregulated | Tretinoin results in decreased expression of BAMBI mRNA | 10p12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | BAMBI | 25805 |
upregulated | Tretinoin results in increased expression of BAMBI mRNA | 10p12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | BANK1 | 55024 |
downregulated | Tretinoin results in decreased expression of BANK1 mRNA | 4q24 | |
| Tretinoin | Approved Investigational Nutraceutical | BASP1 | 10409 |
downregulated | Tretinoin results in decreased expression of BASP1 mRNA | 5p15.1 | |
| Tretinoin | Approved Investigational Nutraceutical | BATF2 | 116071 |
upregulated | Tretinoin results in increased expression of BATF2 mRNA | 11q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | BATF3 | 55509 |
upregulated | Tretinoin results in increased expression of BATF3 mRNA | 1q32.3 | |
| Tretinoin | Approved Investigational Nutraceutical | BAX | 581 |
upregulated | Tretinoin results in increased expression of BAX mRNA | 19q13.33 | |
| Tretinoin | Approved Investigational Nutraceutical | BAZ1A | 11177 |
downregulated | Tretinoin results in decreased expression of BAZ1A mRNA | 14q13.1-q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | BAZ2B | 29994 |
upregulated | Tretinoin results in increased expression of BAZ2B mRNA | 2q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | BBOX1 | 8424 |
downregulated | Tretinoin results in decreased expression of BBOX1 mRNA | 11p14.2 | |
| Tretinoin | Approved Investigational Nutraceutical | BBOX1 | 8424 |
upregulated | Tretinoin results in increased expression of BBOX1 mRNA | 11p14.2 | |
| Tretinoin | Approved Investigational Nutraceutical | BBS2 | 583 |
upregulated | Tretinoin results in increased expression of BBS2 mRNA | 16q13 | |
| Tretinoin | Approved Investigational Nutraceutical | BCAP29 | 55973 |
upregulated | Tretinoin results in increased expression of BCAP29 mRNA | 7q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | BCAR3 | 8412 |
upregulated | Tretinoin results in increased expression of BCAR3 mRNA | 1p22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | BCAT1 | 586 |
downregulated | Tretinoin results in decreased expression of BCAT1 mRNA | 12p12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | BCAT2 | 587 |
downregulated | Tretinoin results in decreased expression of BCAT2 mRNA | 19q13.33 | |
| Tretinoin | Approved Investigational Nutraceutical | BCCIP | 56647 |
upregulated | Tretinoin results in increased expression of BCCIP mRNA | 10q26.2 | |
| Tretinoin | Approved Investigational Nutraceutical | BCL11A | 53335 |
downregulated | Tretinoin results in decreased expression of BCL11A mRNA | 2p16.1 | |
| Tretinoin | Approved Investigational Nutraceutical | BCL2 | 596 |
downregulated | Tretinoin results in decreased expression of BCL2 mRNA | 18q21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | BCL2 | 596 |
upregulated | Tretinoin results in increased expression of BCL2 mRNA | 18q21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | BCL2A1 | 597 |
upregulated | Tretinoin results in increased expression of BCL2A1 mRNA | 15q25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | BCL2L13 | 23786 |
downregulated | Tretinoin results in decreased expression of BCL2L13 mRNA | 22q11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | BCL3 | 602 |
upregulated | Tretinoin results in increased expression of BCL3 mRNA | 19q13.32 | |